Oncotarget Cigarette Smoke and Weak DNA Repair: A Double Hit Behind Lung Cancer Risk Lung cancer remains the leading cause of cancer-related fatalities in the United States and worldwide,... read more August 11, 2025
Oncotarget A New Way to Target Resistant Prostate Cancer Cells Currently, there is no effective therapy for CRPC."Prostate cancer is the second most diagnosed... read more July 29, 2025
Oncotarget PRDX1 Identified as Key to Chemotherapy Resistance in Cancer Cells targeting PRDX1 should sensitize tumours to DNA-damaging agents."Scientists have uncovered a promising new strategy... read more July 14, 2025
Oncotarget Immunotherapy Safety for Hepatocellular Carcinoma in Latin America: Insights from a Real-World Study Latin America has been underrepresented in trials evaluating immunotherapy for hepatocellular carcinoma (HCC)."Liver cancer,... read more July 2, 2025
Oncotarget Exploring a Combined Approach: Radiation and Immunotherapy in Bladder Cancer Different treatment strategies are required for the non-muscle-invasive, muscle-invasive, and metastatic stages of bladder cancer."... read more June 16, 2025
Oncotarget Oncotarget Sponsors Open Access Team in 2025 Ride for Roswell Impact Journals, the publisher of Oncotarget, is once again proudly sponsoring the Open Access Team... read more June 10, 2025
Oncotarget Experimental Triple Therapy Improves Survival in Glioblastoma Mouse Model There are more than 13,000 new cases of malignant brain tumors diagnosed each year... read more June 4, 2025
Oncotarget Engineered Proteins Show Promise in Stopping Glioblastoma Invasion The results demonstrated that the minimal TIMP variants, mTC1, and mTC3, effectively inhibit MMP activity... read more May 21, 2025
Oncotarget Panitumumab and Low-Dose Capecitabine: A Promising Maintenance Therapy for Metastatic Colorectal Cancer Considerations around maintenance therapy are of particular importance when drugs associated with cumulative neurotoxicity like... read more May 7, 2025
Oncotarget New Insights into p53: A Powerful Gene’s Role in Cancer Therapy studies that employ TP53-wild type cancer cells and their isogenic derivatives may systematically fail to... read more April 22, 2025